Search - tctmd.com

Displaying 241 - 260 of 322

Sort: Relevancy | Date

Presentation TCT 2015

Debate 1: Does Alcohol Septal Ablation Increase the Risk for Sudden Cardiac Death? Yes, Definitely!

Presenter: Srihari S. Naidu, Paul Sorajja, Valerian Fernandes

October 15, 2015

Presentation TCT 2015

HCM Ablation Step-by-Step Approach, Complications, and Long-term Outcomes

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Valerian Fernandes

October 15, 2015

Presentation TCT 2015

CTA for Procedure Planning

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Jorge Gaspar

October 15, 2015

Presentation TCT 2015

Indications for Septal Reduction Therapy

Presenter: John S. Douglas Jr, Sherif F. Nagueh

October 15, 2015

Presentation TCT 2015

Medical Management: Agents and Effectiveness

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Mark V. Sherrid

October 15, 2015

Presentation TCT 2015

Pathophysiology and Natural History

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Mark V. Sherrid

October 15, 2015

Presentation TCT 2015

Severe Septal Bulge (± Hypertrophic Cardiomyopathy) and TAVR: Thoughtful Commentary on the Case

Presenter: D. Craig Miller, Alec S. Vahanian, Jan Kovac

October 12, 2015

Presentation TCT 2015

Severe Septal Bulge (± Hypertrophic Cardiomyopathy) and TAVR: Case Presentation

Presenter: D. Craig Miller, Alec S. Vahanian, Mayra Guerrero

October 12, 2015

News Industry News

MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy

October 07, 2015

News Featured Fellow

Jesse Naghi, MD

Yael L. Maxwell

June 11, 2015

Presentation CATCH-UP 2015

Hypertrophic Cardiomyopathy

Presenter: Farhana Latif

April 25, 2015

News Industry News

Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

September 17, 2014

Presentation TCT 2014

TCT 64: Coil Embolization for Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: Long-term Results

Presenter: Igor F. Palacios, Augusto D. Pichard, Kishore J. Harjai, Israel Guerrero Mantilla, MD

September 16, 2014

Presentation TCT 2014

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Igor F. Palacios, Augusto D. Pichard, Kishore J. Harjai, Malek Al-Hawwas, MD

September 16, 2014

Presentation TCT 2014

Interventional Perspective: Not Surgery of Course!

Presenter: Carey D. Kimmelstiel

September 16, 2014

Presentation TCT 2014

Surgeon's Perspective on HOCM surgery

Presenter: John D. Puskas

September 16, 2014

Presentation TCT 2014

Long-term Outcomes Following Alcohol Septal Ablation: Is the Procedure Durable?

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

Complications of Alcohol Septal Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

Patient Management Post Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

HCM Ablation Step-by-Step and Avoiding Potential Pitfalls

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh, Valerian Fernandes

September 16, 2014

Advertisement

Debate 1: Does Alcohol Septal Ablation Increase the Risk for Sudden Cardiac Death? Yes, Definitely!

HCM Ablation Step-by-Step Approach, Complications, and Long-term Outcomes

CTA for Procedure Planning

Indications for Septal Reduction Therapy

Medical Management: Agents and Effectiveness

Pathophysiology and Natural History

Severe Septal Bulge (± Hypertrophic Cardiomyopathy) and TAVR: Thoughtful Commentary on the Case

Severe Septal Bulge (± Hypertrophic Cardiomyopathy) and TAVR: Case Presentation

MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy

Jesse Naghi, MD

Hypertrophic Cardiomyopathy

Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

TCT 64: Coil Embolization for Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: Long-term Results

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Interventional Perspective: Not Surgery of Course!

Surgeon's Perspective on HOCM surgery

Long-term Outcomes Following Alcohol Septal Ablation: Is the Procedure Durable?

Complications of Alcohol Septal Ablation

Patient Management Post Ablation

HCM Ablation Step-by-Step and Avoiding Potential Pitfalls

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content